

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 5.97717311 |
| 2 | triglyceride catabolic process (GO:0019433) | 5.43251767 |
| 3 | polarized epithelial cell differentiation (GO:0030859) | 5.38616648 |
| 4 | establishment of apical/basal cell polarity (GO:0035089) | 5.10086443 |
| 5 | acylglycerol catabolic process (GO:0046464) | 4.94683641 |
| 6 | neutral lipid catabolic process (GO:0046461) | 4.94683641 |
| 7 | regulation of sequestering of triglyceride (GO:0010889) | 4.90717637 |
| 8 | regulation of cardioblast differentiation (GO:0051890) | 4.88702483 |
| 9 | muscle filament sliding (GO:0030049) | 4.78775163 |
| 10 | actin-myosin filament sliding (GO:0033275) | 4.78775163 |
| 11 | NADH metabolic process (GO:0006734) | 4.61838646 |
| 12 | cardiac myofibril assembly (GO:0055003) | 4.52803856 |
| 13 | molting cycle (GO:0042303) | 4.48362233 |
| 14 | hair cycle (GO:0042633) | 4.48362233 |
| 15 | endocardial cushion development (GO:0003197) | 4.39003116 |
| 16 | hemidesmosome assembly (GO:0031581) | 4.36997072 |
| 17 | atrioventricular valve morphogenesis (GO:0003181) | 4.31828972 |
| 18 | establishment of monopolar cell polarity (GO:0061162) | 4.27197220 |
| 19 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.27197220 |
| 20 | peptidyl-proline hydroxylation (GO:0019511) | 4.19629061 |
| 21 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.17663787 |
| 22 | actin-mediated cell contraction (GO:0070252) | 4.11129243 |
| 23 | desmosome organization (GO:0002934) | 4.09202141 |
| 24 | collagen fibril organization (GO:0030199) | 3.97566442 |
| 25 | cellular response to epinephrine stimulus (GO:0071872) | 3.93402889 |
| 26 | NIK/NF-kappaB signaling (GO:0038061) | 3.88117828 |
| 27 | basement membrane organization (GO:0071711) | 3.86335703 |
| 28 | myofibril assembly (GO:0030239) | 3.86160897 |
| 29 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.83006881 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.81006104 |
| 31 | phospholipid homeostasis (GO:0055091) | 3.75291481 |
| 32 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.74606124 |
| 33 | epithelial cell-cell adhesion (GO:0090136) | 3.74571212 |
| 34 | sarcomere organization (GO:0045214) | 3.72401310 |
| 35 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.69408449 |
| 36 | mesenchymal cell proliferation (GO:0010463) | 3.66780168 |
| 37 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.64527806 |
| 38 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.64509832 |
| 39 | keratan sulfate catabolic process (GO:0042340) | 3.56584626 |
| 40 | endoderm formation (GO:0001706) | 3.55936533 |
| 41 | protein heterotrimerization (GO:0070208) | 3.54929480 |
| 42 | embryonic foregut morphogenesis (GO:0048617) | 3.49754747 |
| 43 | protein hydroxylation (GO:0018126) | 3.49186143 |
| 44 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.44717101 |
| 45 | regulation of heart morphogenesis (GO:2000826) | 3.44096667 |
| 46 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.43454521 |
| 47 | coronary vasculature morphogenesis (GO:0060977) | 3.41448300 |
| 48 | negative regulation of norepinephrine secretion (GO:0010700) | 3.41418989 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 3.40060007 |
| 50 | endodermal cell differentiation (GO:0035987) | 3.39899803 |
| 51 | glycerolipid catabolic process (GO:0046503) | 3.36149370 |
| 52 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.34756178 |
| 53 | fatty acid homeostasis (GO:0055089) | 3.34639983 |
| 54 | diacylglycerol metabolic process (GO:0046339) | 3.34439143 |
| 55 | actin filament-based movement (GO:0030048) | 3.31374911 |
| 56 | bone trabecula formation (GO:0060346) | 3.28612383 |
| 57 | response to epinephrine (GO:0071871) | 3.27899242 |
| 58 | fibril organization (GO:0097435) | 3.18080172 |
| 59 | chondrocyte development (GO:0002063) | 3.17616405 |
| 60 | regulation of skeletal muscle contraction (GO:0014819) | 3.17610936 |
| 61 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.17021975 |
| 62 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 3.16265499 |
| 63 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 3.15586339 |
| 64 | cardiac right ventricle morphogenesis (GO:0003215) | 3.15570450 |
| 65 | adherens junction assembly (GO:0034333) | 3.14871368 |
| 66 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.11202573 |
| 67 | regulation of cardioblast proliferation (GO:0003264) | 3.10537007 |
| 68 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.10537007 |
| 69 | focal adhesion assembly (GO:0048041) | 3.10292095 |
| 70 | cell-substrate adherens junction assembly (GO:0007045) | 3.10292095 |
| 71 | cell migration involved in heart development (GO:0060973) | 3.09558325 |
| 72 | establishment of epithelial cell polarity (GO:0090162) | 3.07836232 |
| 73 | regulation of cholesterol storage (GO:0010885) | 3.07827406 |
| 74 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.07372650 |
| 75 | positive regulation of cell size (GO:0045793) | 3.07355390 |
| 76 | wound healing, spreading of epidermal cells (GO:0035313) | 3.07206133 |
| 77 | outflow tract septum morphogenesis (GO:0003148) | 3.06616784 |
| 78 | triglyceride homeostasis (GO:0070328) | 3.06237718 |
| 79 | acylglycerol homeostasis (GO:0055090) | 3.06237718 |
| 80 | negative regulation of fatty acid transport (GO:2000192) | 3.04471628 |
| 81 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.04070101 |
| 82 | positive regulation of stem cell differentiation (GO:2000738) | 3.03223046 |
| 83 | cGMP-mediated signaling (GO:0019934) | 3.03185649 |
| 84 | negative regulation of platelet activation (GO:0010544) | 3.02910414 |
| 85 | chondrocyte proliferation (GO:0035988) | 3.02691407 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 3.01540666 |
| 87 | negative regulation of cell fate specification (GO:0009996) | 3.00672984 |
| 88 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.00156353 |
| 89 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.99736853 |
| 90 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.98641159 |
| 91 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.98112749 |
| 92 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.97794247 |
| 93 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.97269877 |
| 94 | plasma membrane repair (GO:0001778) | 2.96803864 |
| 95 | atrial septum morphogenesis (GO:0060413) | 2.96513268 |
| 96 | positive regulation of cartilage development (GO:0061036) | 2.96228537 |
| 97 | heart valve morphogenesis (GO:0003179) | 2.93110563 |
| 98 | positive regulation of vasculogenesis (GO:2001214) | 2.91858379 |
| 99 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.91221854 |
| 100 | regulation of lipoprotein metabolic process (GO:0050746) | 2.90973151 |
| 101 | mesenchyme morphogenesis (GO:0072132) | 2.90733993 |
| 102 | actomyosin structure organization (GO:0031032) | 2.89855117 |
| 103 | positive regulation of BMP signaling pathway (GO:0030513) | 2.89444027 |
| 104 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.89379300 |
| 105 | striated muscle hypertrophy (GO:0014897) | 2.88658439 |
| 106 | regulation of striated muscle cell apoptotic process (GO:0010662) | 2.87804976 |
| 107 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.86004266 |
| 108 | transcytosis (GO:0045056) | 2.85925521 |
| 109 | muscle tissue morphogenesis (GO:0060415) | 2.83833352 |
| 110 | positive regulation of receptor recycling (GO:0001921) | 2.83753069 |
| 111 | negative regulation of stress fiber assembly (GO:0051497) | 2.82747654 |
| 112 | skin morphogenesis (GO:0043589) | 2.81875867 |
| 113 | outer ear morphogenesis (GO:0042473) | 2.81673772 |
| 114 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.81636852 |
| 115 | lipid particle organization (GO:0034389) | 2.81501476 |
| 116 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.81363671 |
| 117 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.81352653 |
| 118 | lymph vessel development (GO:0001945) | 2.81321247 |
| 119 | glycogen catabolic process (GO:0005980) | 2.77024508 |
| 120 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.76803149 |
| 121 | heart process (GO:0003015) | 2.76688594 |
| 122 | heart contraction (GO:0060047) | 2.76688594 |
| 123 | cartilage morphogenesis (GO:0060536) | 2.76655125 |
| 124 | body morphogenesis (GO:0010171) | 2.75875922 |
| 125 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.75459883 |
| 126 | hippo signaling (GO:0035329) | 2.75037035 |
| 127 | axon extension involved in axon guidance (GO:0048846) | 2.74717723 |
| 128 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.74717723 |
| 129 | cell proliferation involved in metanephros development (GO:0072203) | 2.74333274 |
| 130 | cardiac muscle hypertrophy (GO:0003300) | 2.73992709 |
| 131 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.73932626 |
| 132 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.73932626 |
| 133 | regulation of p38MAPK cascade (GO:1900744) | 2.73005447 |
| 134 | cardiac muscle cell development (GO:0055013) | 2.71968806 |
| 135 | 4-hydroxyproline metabolic process (GO:0019471) | 2.70953458 |
| 136 | * regulation of transforming growth factor beta2 production (GO:0032909) | 2.70447721 |
| 137 | extracellular matrix disassembly (GO:0022617) | 2.69991077 |
| 138 | collagen metabolic process (GO:0032963) | 2.69360619 |
| 139 | lipid storage (GO:0019915) | 2.69166237 |
| 140 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.68790354 |
| 141 | extracellular fibril organization (GO:0043206) | 2.67874448 |
| 142 | cell-substrate junction assembly (GO:0007044) | 2.67514304 |
| 143 | endothelium development (GO:0003158) | 2.67469721 |
| 144 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.66417368 |
| 145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.66099658 |
| 146 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.66099658 |
| 147 | triglyceride metabolic process (GO:0006641) | 2.65959514 |
| 148 | endocrine hormone secretion (GO:0060986) | 2.64109136 |
| 149 | paraxial mesoderm development (GO:0048339) | 2.63777434 |
| 150 | muscle cell fate commitment (GO:0042693) | 2.63430045 |
| 151 | white fat cell differentiation (GO:0050872) | 2.62908198 |
| 152 | response to water (GO:0009415) | 2.62465466 |
| 153 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.62294913 |
| 154 | fatty acid transmembrane transport (GO:1902001) | 2.61591529 |
| 155 | triglyceride biosynthetic process (GO:0019432) | 2.60907331 |
| 156 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.60882788 |
| 157 | blood coagulation, intrinsic pathway (GO:0007597) | 2.60521348 |
| 158 | positive regulation of lipid storage (GO:0010884) | 2.59987113 |
| 159 | glucan catabolic process (GO:0009251) | 2.59118447 |
| 160 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.59023403 |
| 161 | phosphatidic acid metabolic process (GO:0046473) | 2.58194212 |
| 162 | phosphatidic acid biosynthetic process (GO:0006654) | 2.58194212 |
| 163 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.57114114 |
| 164 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.56445282 |
| 165 | positive regulation of glomerulus development (GO:0090193) | 2.55367841 |
| 166 | barbed-end actin filament capping (GO:0051016) | 2.54935486 |
| 167 | angiogenesis involved in wound healing (GO:0060055) | 2.52606412 |
| 168 | regulation of vasculogenesis (GO:2001212) | 2.52327191 |
| 169 | response to dietary excess (GO:0002021) | 2.51606267 |
| 170 | cellular response to lithium ion (GO:0071285) | 2.51394503 |
| 171 | notochord development (GO:0030903) | 2.51046102 |
| 172 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.50832855 |
| 173 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.50621282 |
| 174 | acylglycerol biosynthetic process (GO:0046463) | 2.50498371 |
| 175 | neutral lipid biosynthetic process (GO:0046460) | 2.50498371 |
| 176 | * protein localization to cell surface (GO:0034394) | 2.49350572 |
| 177 | acylglycerol metabolic process (GO:0006639) | 2.48596866 |
| 178 | high-density lipoprotein particle remodeling (GO:0034375) | 2.46953862 |
| 179 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.46887562 |
| 180 | neutral lipid metabolic process (GO:0006638) | 2.46816404 |
| 181 | negative regulation of lipase activity (GO:0060192) | 2.46799263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.99966953 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.12027502 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.79436819 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.71031860 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.37964295 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.96072902 |
| 7 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.90984950 |
| 8 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.79144774 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.69611018 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.49312356 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.47702102 |
| 12 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.41471784 |
| 13 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.39591508 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.33655262 |
| 15 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.31881929 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.28769884 |
| 17 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.20892434 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15820010 |
| 19 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.15511347 |
| 20 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.14626593 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.13174829 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.12006935 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.07729484 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.03564847 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.02950189 |
| 26 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.98223868 |
| 27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.97255817 |
| 28 | CJUN_26792858_Chip-Seq_BT549_Human | 1.94625575 |
| 29 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.86429052 |
| 30 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.86429052 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86275947 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85508436 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.84678414 |
| 34 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.80283254 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.76439861 |
| 36 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.76278852 |
| 37 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.76278852 |
| 38 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.73305139 |
| 39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.71840545 |
| 40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.70668844 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52707434 |
| 42 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.50899736 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49582073 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48321202 |
| 45 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.47896332 |
| 46 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.47727813 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.47259509 |
| 48 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47045892 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46854506 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.46294969 |
| 51 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.44196835 |
| 52 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.44196835 |
| 53 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.44196835 |
| 54 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44141655 |
| 55 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43454050 |
| 56 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.41740613 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.37371411 |
| 58 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36962622 |
| 59 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36962622 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36764152 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36642639 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35117098 |
| 63 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.34279500 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32046999 |
| 65 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29267560 |
| 66 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.28865873 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28500986 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.28152612 |
| 69 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.27781223 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27485935 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.27101756 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27026600 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26126373 |
| 74 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.25164082 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.25011071 |
| 76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23152135 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22520546 |
| 78 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.22349700 |
| 79 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21150131 |
| 80 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20982034 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20416448 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19781310 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19545141 |
| 84 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.19409583 |
| 85 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19008210 |
| 86 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.18917199 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18697535 |
| 88 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.17702526 |
| 89 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17474186 |
| 90 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.16927116 |
| 91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16885566 |
| 92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16207201 |
| 93 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15436276 |
| 94 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.15324487 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14628165 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14567058 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.14181877 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12674211 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12184856 |
| 100 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.11659755 |
| 101 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11313687 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10491631 |
| 103 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10008244 |
| 104 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.08957727 |
| 105 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08116789 |
| 106 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07544501 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06575993 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05003508 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03488367 |
| 110 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.03398943 |
| 111 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03076927 |
| 112 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02568566 |
| 113 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02481886 |
| 114 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02407546 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01301301 |
| 116 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00763685 |
| 117 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98973351 |
| 118 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.98220774 |
| 119 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97994428 |
| 120 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97929390 |
| 121 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97901446 |
| 122 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97481833 |
| 123 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96958310 |
| 124 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96525707 |
| 125 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95884635 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95505545 |
| 127 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.95380578 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94577658 |
| 129 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.94041056 |
| 130 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.93073060 |
| 131 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92975660 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92307768 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92307768 |
| 134 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92187392 |
| 135 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.91727335 |
| 136 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.91482760 |
| 137 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91343164 |
| 138 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91187505 |
| 139 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91168325 |
| 140 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90896501 |
| 141 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90750403 |
| 142 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90626114 |
| 143 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90366180 |
| 144 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88996549 |
| 145 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87746619 |
| 146 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87495384 |
| 147 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86796039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 5.19674260 |
| 2 | MP0005275_abnormal_skin_tensile | 4.27020386 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 4.20073210 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.91672157 |
| 5 | MP0005666_abnormal_adipose_tissue | 3.90569330 |
| 6 | MP0004272_abnormal_basement_membrane | 3.69237452 |
| 7 | MP0004130_abnormal_muscle_cell | 3.45814505 |
| 8 | MP0005503_abnormal_tendon_morphology | 3.25212243 |
| 9 | MP0005623_abnormal_meninges_morphology | 3.10477998 |
| 10 | MP0005375_adipose_tissue_phenotype | 2.95165946 |
| 11 | MP0002254_reproductive_system_inflammat | 2.87794765 |
| 12 | MP0004185_abnormal_adipocyte_glucose | 2.86674722 |
| 13 | MP0009384_cardiac_valve_regurgitation | 2.68247722 |
| 14 | MP0002971_abnormal_brown_adipose | 2.52968595 |
| 15 | MP0004510_myositis | 2.45658586 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.34161284 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.12470754 |
| 18 | MP0000003_abnormal_adipose_tissue | 2.05294360 |
| 19 | MP0003566_abnormal_cell_adhesion | 1.96564255 |
| 20 | MP0000749_muscle_degeneration | 1.95301339 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 1.93841028 |
| 22 | MP0009053_abnormal_anal_canal | 1.90293117 |
| 23 | MP0000751_myopathy | 1.88206232 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.85115812 |
| 25 | MP0004858_abnormal_nervous_system | 1.84845975 |
| 26 | MP0006138_congestive_heart_failure | 1.81554241 |
| 27 | MP0009115_abnormal_fat_cell | 1.76355379 |
| 28 | MP0009250_abnormal_appendicular_skeleto | 1.75664968 |
| 29 | MP0001348_abnormal_lacrimal_gland | 1.75601322 |
| 30 | MP0003646_muscle_fatigue | 1.74989755 |
| 31 | MP0003279_aneurysm | 1.70549133 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.67662670 |
| 33 | MP0003385_abnormal_body_wall | 1.66617469 |
| 34 | MP0003941_abnormal_skin_development | 1.64267245 |
| 35 | MP0000762_abnormal_tongue_morphology | 1.64245880 |
| 36 | MP0001958_emphysema | 1.63602550 |
| 37 | MP0000579_abnormal_nail_morphology | 1.61710676 |
| 38 | MP0003567_abnormal_fetal_cardiomyocyte | 1.61007697 |
| 39 | MP0002282_abnormal_trachea_morphology | 1.60582625 |
| 40 | MP0004036_abnormal_muscle_relaxation | 1.60264316 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.59521143 |
| 42 | MP0003123_paternal_imprinting | 1.57980753 |
| 43 | MP0010030_abnormal_orbit_morphology | 1.57751373 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.54439591 |
| 45 | MP0003878_abnormal_ear_physiology | 1.54439591 |
| 46 | MP0004087_abnormal_muscle_fiber | 1.51484858 |
| 47 | MP0001661_extended_life_span | 1.51415721 |
| 48 | MP0003828_pulmonary_edema | 1.50065793 |
| 49 | MP0003879_abnormal_hair_cell | 1.48072777 |
| 50 | MP0002060_abnormal_skin_morphology | 1.44593270 |
| 51 | MP0000733_abnormal_muscle_development | 1.43648446 |
| 52 | MP0004215_abnormal_myocardial_fiber | 1.41506092 |
| 53 | MP0006054_spinal_hemorrhage | 1.41424093 |
| 54 | MP0001243_abnormal_dermal_layer | 1.41237441 |
| 55 | MP0005508_abnormal_skeleton_morphology | 1.40125485 |
| 56 | MP0002970_abnormal_white_adipose | 1.35832356 |
| 57 | MP0005334_abnormal_fat_pad | 1.34703185 |
| 58 | * MP0003942_abnormal_urinary_system | 1.33306813 |
| 59 | MP0002106_abnormal_muscle_physiology | 1.31622578 |
| 60 | MP0000537_abnormal_urethra_morphology | 1.31069903 |
| 61 | MP0002972_abnormal_cardiac_muscle | 1.30222410 |
| 62 | MP0002933_joint_inflammation | 1.29859532 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.29463779 |
| 64 | MP0009840_abnormal_foam_cell | 1.29075292 |
| 65 | MP0010630_abnormal_cardiac_muscle | 1.28754411 |
| 66 | MP0002009_preneoplasia | 1.28561034 |
| 67 | MP0000534_abnormal_ureter_morphology | 1.28333123 |
| 68 | MP0008004_abnormal_stomach_pH | 1.28062038 |
| 69 | MP0003959_abnormal_lean_body | 1.27699462 |
| 70 | MP0002098_abnormal_vibrissa_morphology | 1.27699117 |
| 71 | MP0003122_maternal_imprinting | 1.26792123 |
| 72 | MP0008775_abnormal_heart_ventricle | 1.26242184 |
| 73 | MP0000767_abnormal_smooth_muscle | 1.24406136 |
| 74 | MP0000343_altered_response_to | 1.23761709 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.23516124 |
| 76 | MP0000049_abnormal_middle_ear | 1.20247426 |
| 77 | MP0005620_abnormal_muscle_contractility | 1.18577615 |
| 78 | MP0000163_abnormal_cartilage_morphology | 1.17639456 |
| 79 | MP0005369_muscle_phenotype | 1.16246966 |
| 80 | MP0000013_abnormal_adipose_tissue | 1.16221806 |
| 81 | MP0002127_abnormal_cardiovascular_syste | 1.15905841 |
| 82 | MP0003115_abnormal_respiratory_system | 1.14330139 |
| 83 | MP0000759_abnormal_skeletal_muscle | 1.14276616 |
| 84 | MP0003937_abnormal_limbs/digits/tail_de | 1.13507491 |
| 85 | MP0005330_cardiomyopathy | 1.12006124 |
| 86 | MP0001879_abnormal_lymphatic_vessel | 1.11968763 |
| 87 | MP0005409_darkened_coat_color | 1.09583069 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 1.09343541 |
| 89 | MP0002876_abnormal_thyroid_physiology | 1.09141747 |
| 90 | MP0000750_abnormal_muscle_regeneration | 1.07853974 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 1.07373125 |
| 92 | MP0003091_abnormal_cell_migration | 1.06860923 |
| 93 | MP0005385_cardiovascular_system_phenoty | 1.05869328 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 1.05869328 |
| 95 | MP0002115_abnormal_skeleton_extremities | 1.05381707 |
| 96 | MP0002234_abnormal_pharynx_morphology | 1.03698443 |
| 97 | MP0002249_abnormal_larynx_morphology | 1.03254321 |
| 98 | MP0002108_abnormal_muscle_morphology | 1.02267125 |
| 99 | MP0005448_abnormal_energy_balance | 1.00876449 |
| 100 | MP0003011_delayed_dark_adaptation | 0.99947200 |
| 101 | MP0003191_abnormal_cellular_cholesterol | 0.99209241 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.97600361 |
| 103 | MP0003868_abnormal_feces_composition | 0.96742093 |
| 104 | MP0003755_abnormal_palate_morphology | 0.95924516 |
| 105 | MP0005535_abnormal_body_temperature | 0.95825062 |
| 106 | MP0004484_altered_response_of | 0.94966090 |
| 107 | MP0005023_abnormal_wound_healing | 0.94748186 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.94716384 |
| 109 | MP0002166_altered_tumor_susceptibility | 0.94407827 |
| 110 | MP0010352_gastrointestinal_tract_polyps | 0.94361395 |
| 111 | MP0000747_muscle_weakness | 0.93047121 |
| 112 | MP0002796_impaired_skin_barrier | 0.92058745 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.91999665 |
| 114 | MP0002269_muscular_atrophy | 0.91808163 |
| 115 | MP0002295_abnormal_pulmonary_circulatio | 0.91284509 |
| 116 | MP0002896_abnormal_bone_mineralization | 0.90946194 |
| 117 | MP0002109_abnormal_limb_morphology | 0.89109461 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.88838845 |
| 119 | MP0002932_abnormal_joint_morphology | 0.88326357 |
| 120 | MP0000516_abnormal_urinary_system | 0.88239690 |
| 121 | MP0005367_renal/urinary_system_phenotyp | 0.88239690 |
| 122 | MP0002113_abnormal_skeleton_development | 0.87173328 |
| 123 | MP0005451_abnormal_body_composition | 0.87100630 |
| 124 | MP0005390_skeleton_phenotype | 0.85846905 |
| 125 | MP0003724_increased_susceptibility_to | 0.84731733 |
| 126 | MP0000383_abnormal_hair_follicle | 0.84403116 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.84390593 |
| 128 | MP0000377_abnormal_hair_follicle | 0.83063710 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.82507108 |
| 130 | MP0004134_abnormal_chest_morphology | 0.81175689 |
| 131 | MP0002925_abnormal_cardiovascular_devel | 0.80591296 |
| 132 | MP0005595_abnormal_vascular_smooth | 0.80558278 |
| 133 | MP0000249_abnormal_blood_vessel | 0.79897887 |
| 134 | MP0001175_abnormal_lung_morphology | 0.78973990 |
| 135 | MP0005501_abnormal_skin_physiology | 0.78674343 |
| 136 | MP0001270_distended_abdomen | 0.78665011 |
| 137 | MP0002128_abnormal_blood_circulation | 0.78017781 |
| 138 | MP0003119_abnormal_digestive_system | 0.77699501 |
| 139 | MP0003935_abnormal_craniofacial_develop | 0.76611746 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.76240547 |
| 141 | MP0002909_abnormal_adrenal_gland | 0.73459446 |
| 142 | MP0003186_abnormal_redox_activity | 0.72579527 |
| 143 | MP0000462_abnormal_digestive_system | 0.71210085 |
| 144 | MP0001614_abnormal_blood_vessel | 0.68810379 |
| 145 | MP0005083_abnormal_biliary_tract | 0.65103175 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.65003247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.39424251 |
| 2 | Protrusio acetabuli (HP:0003179) | 4.27376589 |
| 3 | Type 1 muscle fiber predominance (HP:0003803) | 3.98221825 |
| 4 | Acanthosis nigricans (HP:0000956) | 3.63333589 |
| 5 | Increased mean platelet volume (HP:0011877) | 3.56594896 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 3.54081004 |
| 7 | Prolonged bleeding time (HP:0003010) | 3.49478465 |
| 8 | Mesomelia (HP:0003027) | 3.42023090 |
| 9 | Shallow orbits (HP:0000586) | 3.38103702 |
| 10 | Oligomenorrhea (HP:0000876) | 3.33539929 |
| 11 | Menorrhagia (HP:0000132) | 3.32324239 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.26929326 |
| 13 | Increased connective tissue (HP:0009025) | 3.26845862 |
| 14 | Right ventricular cardiomyopathy (HP:0011663) | 3.22640271 |
| 15 | Hypertriglyceridemia (HP:0002155) | 3.16151621 |
| 16 | Abnormal platelet volume (HP:0011876) | 3.13519564 |
| 17 | Atrophic scars (HP:0001075) | 3.08978804 |
| 18 | Epiphyseal dysplasia (HP:0002656) | 3.00505150 |
| 19 | Cerebral aneurysm (HP:0004944) | 2.91307647 |
| 20 | Muscle fiber splitting (HP:0003555) | 2.89183284 |
| 21 | Paralysis (HP:0003470) | 2.86541751 |
| 22 | Abnormality of dentin (HP:0010299) | 2.86086324 |
| 23 | Metaphyseal dysplasia (HP:0100255) | 2.80026390 |
| 24 | Purpura (HP:0000979) | 2.79713817 |
| 25 | Petechiae (HP:0000967) | 2.78727052 |
| 26 | Spinal rigidity (HP:0003306) | 2.78722305 |
| 27 | Sudden death (HP:0001699) | 2.77725263 |
| 28 | Peritonitis (HP:0002586) | 2.76773369 |
| 29 | Distal lower limb amyotrophy (HP:0008944) | 2.76710030 |
| 30 | Hypoplasia of the iris (HP:0007676) | 2.73272563 |
| 31 | Neck muscle weakness (HP:0000467) | 2.73221382 |
| 32 | Rhabdomyolysis (HP:0003201) | 2.68295876 |
| 33 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.66720386 |
| 34 | Ventricular tachycardia (HP:0004756) | 2.58228218 |
| 35 | Hypoplastic ischia (HP:0003175) | 2.58222851 |
| 36 | Neonatal short-limb short stature (HP:0008921) | 2.57359207 |
| 37 | Abnormality of the 2nd finger (HP:0004100) | 2.55313698 |
| 38 | Exercise-induced myalgia (HP:0003738) | 2.55173755 |
| 39 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.50626715 |
| 40 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.48923985 |
| 41 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.47322126 |
| 42 | Calf muscle hypertrophy (HP:0008981) | 2.46596447 |
| 43 | Myoglobinuria (HP:0002913) | 2.46279015 |
| 44 | Abnormality of the calf musculature (HP:0001430) | 2.46184862 |
| 45 | Back pain (HP:0003418) | 2.41793280 |
| 46 | Hyporeflexia of lower limbs (HP:0002600) | 2.40414910 |
| 47 | Aortic dissection (HP:0002647) | 2.39038008 |
| 48 | Round ear (HP:0100830) | 2.38656231 |
| 49 | Difficulty running (HP:0009046) | 2.35909466 |
| 50 | Lymphangioma (HP:0100764) | 2.35705673 |
| 51 | Nausea (HP:0002018) | 2.34794361 |
| 52 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.32602178 |
| 53 | Follicular hyperkeratosis (HP:0007502) | 2.32147342 |
| 54 | Wormian bones (HP:0002645) | 2.31840975 |
| 55 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.31212767 |
| 56 | Single umbilical artery (HP:0001195) | 2.31212767 |
| 57 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.31212767 |
| 58 | Increased variability in muscle fiber diameter (HP:0003557) | 2.29682239 |
| 59 | Ankle contracture (HP:0006466) | 2.27217260 |
| 60 | Advanced eruption of teeth (HP:0006288) | 2.27072351 |
| 61 | Double outlet right ventricle (HP:0001719) | 2.27006669 |
| 62 | Congenital malformation of the right heart (HP:0011723) | 2.27006669 |
| 63 | Hip contracture (HP:0003273) | 2.26956752 |
| 64 | Natal tooth (HP:0000695) | 2.24329325 |
| 65 | Deformed tarsal bones (HP:0008119) | 2.23998677 |
| 66 | Woolly hair (HP:0002224) | 2.23650647 |
| 67 | Hemorrhage of the eye (HP:0011885) | 2.23568603 |
| 68 | Fragile skin (HP:0001030) | 2.23111602 |
| 69 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.21804024 |
| 70 | Bulbar palsy (HP:0001283) | 2.20733654 |
| 71 | Hypoalphalipoproteinemia (HP:0003233) | 2.20646668 |
| 72 | Insulin resistance (HP:0000855) | 2.20635714 |
| 73 | Abnormality of the ischium (HP:0003174) | 2.19833032 |
| 74 | Knee flexion contracture (HP:0006380) | 2.19546577 |
| 75 | Bicornuate uterus (HP:0000813) | 2.18927735 |
| 76 | Metaphyseal cupping (HP:0003021) | 2.17930091 |
| 77 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.17684421 |
| 78 | Myopathic facies (HP:0002058) | 2.16452839 |
| 79 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.14004733 |
| 80 | Calcaneovalgus deformity (HP:0001848) | 2.13025382 |
| 81 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.12417143 |
| 82 | Ulnar deviation of the wrist (HP:0003049) | 2.12149406 |
| 83 | Tarsal synostosis (HP:0008368) | 2.10937590 |
| 84 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.10785877 |
| 85 | Abnormality of the aortic arch (HP:0012303) | 2.10459645 |
| 86 | Gingival bleeding (HP:0000225) | 2.09779437 |
| 87 | Elbow flexion contracture (HP:0002987) | 2.09563219 |
| 88 | Choanal stenosis (HP:0000452) | 2.09497335 |
| 89 | Delayed epiphyseal ossification (HP:0002663) | 2.07661912 |
| 90 | Short hallux (HP:0010109) | 2.06101870 |
| 91 | Soft skin (HP:0000977) | 2.05700093 |
| 92 | Broad metatarsal (HP:0001783) | 2.05424658 |
| 93 | Epistaxis (HP:0000421) | 2.05263475 |
| 94 | Pulmonary artery stenosis (HP:0004415) | 2.04589987 |
| 95 | Aortic aneurysm (HP:0004942) | 2.04564028 |
| 96 | Bell-shaped thorax (HP:0001591) | 2.04388796 |
| 97 | Cupped ribs (HP:0000887) | 2.03685808 |
| 98 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.03535201 |
| 99 | Transposition of the great arteries (HP:0001669) | 2.03535201 |
| 100 | Abnormal connection of the cardiac segments (HP:0011545) | 2.03535201 |
| 101 | Muscle fiber inclusion bodies (HP:0100299) | 2.03422423 |
| 102 | Vertebral compression fractures (HP:0002953) | 2.03021577 |
| 103 | Limited hip movement (HP:0008800) | 2.01830072 |
| 104 | Hypotrichosis (HP:0001006) | 2.01381703 |
| 105 | Abnormal tarsal ossification (HP:0008369) | 2.01181498 |
| 106 | Bladder diverticulum (HP:0000015) | 2.01154434 |
| 107 | Radial bowing (HP:0002986) | 2.01087111 |
| 108 | Flat acetabular roof (HP:0003180) | 1.98861593 |
| 109 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.98352644 |
| 110 | Xanthomatosis (HP:0000991) | 1.97127184 |
| 111 | Growth hormone excess (HP:0000845) | 1.96897497 |
| 112 | Dilated cardiomyopathy (HP:0001644) | 1.96711807 |
| 113 | Distal lower limb muscle weakness (HP:0009053) | 1.96440475 |
| 114 | Blue sclerae (HP:0000592) | 1.96227749 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 1.96149611 |
| 116 | Absent phalangeal crease (HP:0006109) | 1.96148234 |
| 117 | Hypercortisolism (HP:0001578) | 1.95758696 |
| 118 | Distal arthrogryposis (HP:0005684) | 1.95370550 |
| 119 | Hydroxyprolinuria (HP:0003080) | 1.94028969 |
| 120 | Abnormality of proline metabolism (HP:0010907) | 1.94028969 |
| 121 | EMG: myopathic abnormalities (HP:0003458) | 1.90398028 |
| 122 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90307924 |
| 123 | Abnormality of carpal bone ossification (HP:0006257) | 1.89567286 |
| 124 | Lipoatrophy (HP:0100578) | 1.88458907 |
| 125 | Rimmed vacuoles (HP:0003805) | 1.87431298 |
| 126 | Abnormal ossification of hand bones (HP:0005921) | 1.85988719 |
| 127 | Milia (HP:0001056) | 1.85951411 |
| 128 | Fibular aplasia (HP:0002990) | 1.85931989 |
| 129 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.85414651 |
| 130 | Synostosis of carpal bones (HP:0005048) | 1.85344294 |
| 131 | Broad toe (HP:0001837) | 1.84910297 |
| 132 | Mitral stenosis (HP:0001718) | 1.84615106 |
| 133 | Patent foramen ovale (HP:0001655) | 1.84418588 |
| 134 | Femoral bowing (HP:0002980) | 1.84160889 |
| 135 | Flat capital femoral epiphysis (HP:0003370) | 1.84041570 |
| 136 | Coxa vara (HP:0002812) | 1.83959890 |
| 137 | Muscle stiffness (HP:0003552) | 1.83682568 |
| 138 | Venous abnormality (HP:0002624) | 1.83472995 |
| 139 | Synostosis involving bones of the feet (HP:0009140) | 1.82686701 |
| 140 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.82686701 |
| 141 | Mitral valve prolapse (HP:0001634) | 1.82642397 |
| 142 | Slender build (HP:0001533) | 1.82399957 |
| 143 | Nemaline bodies (HP:0003798) | 1.81618755 |
| 144 | Cervical subluxation (HP:0003308) | 1.81220022 |
| 145 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.80614052 |
| 146 | Lower limb amyotrophy (HP:0007210) | 1.77856713 |
| 147 | Myocardial infarction (HP:0001658) | 1.76514230 |
| 148 | Proximal tubulopathy (HP:0000114) | 1.72304299 |
| 149 | Areflexia of lower limbs (HP:0002522) | 1.71553674 |
| 150 | Dysmetric saccades (HP:0000641) | 1.70312571 |
| 151 | Axonal loss (HP:0003447) | 1.69199946 |
| 152 | Ileus (HP:0002595) | 1.69043088 |
| 153 | Scapular winging (HP:0003691) | 1.68538756 |
| 154 | Subcapsular cataract (HP:0000523) | 1.68512869 |
| 155 | Asymmetry of the thorax (HP:0001555) | 1.68113823 |
| 156 | Frequent falls (HP:0002359) | 1.67530957 |
| 157 | Subaortic stenosis (HP:0001682) | 1.66240861 |
| 158 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.66240861 |
| 159 | Generalized muscle weakness (HP:0003324) | 1.65019523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.53983959 |
| 2 | TTN | 3.34171367 |
| 3 | MAPKAPK3 | 3.13426226 |
| 4 | TRIB3 | 3.04314596 |
| 5 | EPHB2 | 2.99363685 |
| 6 | PKN2 | 2.64733653 |
| 7 | DDR2 | 2.64199051 |
| 8 | LATS1 | 2.33164542 |
| 9 | MAP3K3 | 2.18684334 |
| 10 | STK24 | 2.13186120 |
| 11 | RIPK1 | 2.04376040 |
| 12 | PDGFRA | 1.95666056 |
| 13 | PTK6 | 1.80120498 |
| 14 | PIM2 | 1.77997719 |
| 15 | DMPK | 1.76330770 |
| 16 | ARAF | 1.73917659 |
| 17 | TRPM7 | 1.70142687 |
| 18 | MAP3K14 | 1.69178850 |
| 19 | FLT3 | 1.67559919 |
| 20 | LATS2 | 1.67260464 |
| 21 | PTK2 | 1.63634916 |
| 22 | STK38L | 1.63114139 |
| 23 | MYLK | 1.60705058 |
| 24 | LRRK2 | 1.57447380 |
| 25 | FER | 1.45146512 |
| 26 | MAPK15 | 1.44955964 |
| 27 | STK38 | 1.42927938 |
| 28 | NME2 | 1.41436507 |
| 29 | EPHA2 | 1.38230941 |
| 30 | CHUK | 1.35974437 |
| 31 | MAPK12 | 1.35673832 |
| 32 | STK39 | 1.29965296 |
| 33 | LIMK1 | 1.24194750 |
| 34 | IKBKB | 1.23871631 |
| 35 | PIK3CA | 1.21965785 |
| 36 | PAK2 | 1.21949799 |
| 37 | LMTK2 | 1.19558319 |
| 38 | AKT3 | 1.19498295 |
| 39 | MAP2K3 | 1.18841253 |
| 40 | STK3 | 1.18405163 |
| 41 | MST1R | 1.18112154 |
| 42 | PTK2B | 1.16956034 |
| 43 | MAP3K10 | 1.14806823 |
| 44 | MAP3K13 | 1.13705650 |
| 45 | NEK9 | 1.13301640 |
| 46 | ILK | 1.11081505 |
| 47 | SIK1 | 1.09593294 |
| 48 | TYK2 | 1.09497653 |
| 49 | RPS6KA4 | 1.07371442 |
| 50 | PRKAA2 | 1.05233795 |
| 51 | BMX | 1.03629593 |
| 52 | ABL2 | 1.02644979 |
| 53 | RPS6KC1 | 0.99534943 |
| 54 | RPS6KL1 | 0.99534943 |
| 55 | OXSR1 | 0.98800497 |
| 56 | TESK1 | 0.96564795 |
| 57 | PDPK1 | 0.95060561 |
| 58 | CDC42BPA | 0.92052237 |
| 59 | RPS6KA6 | 0.91744675 |
| 60 | FGFR1 | 0.90988518 |
| 61 | MAPKAPK2 | 0.89577264 |
| 62 | ROCK1 | 0.89502468 |
| 63 | PHKG1 | 0.88610889 |
| 64 | PHKG2 | 0.88610889 |
| 65 | PDGFRB | 0.88560816 |
| 66 | NME1 | 0.88391316 |
| 67 | JAK3 | 0.87854526 |
| 68 | TGFBR1 | 0.85145960 |
| 69 | RPS6KA2 | 0.84923402 |
| 70 | ICK | 0.83657367 |
| 71 | FGFR3 | 0.82152148 |
| 72 | AKT2 | 0.77128102 |
| 73 | JAK1 | 0.76846365 |
| 74 | TBK1 | 0.76569400 |
| 75 | PDK2 | 0.76011040 |
| 76 | MAPK11 | 0.75428135 |
| 77 | MAP2K2 | 0.74511179 |
| 78 | MAP3K12 | 0.73688052 |
| 79 | MST4 | 0.73324355 |
| 80 | CAMK1 | 0.72329181 |
| 81 | EPHA3 | 0.70712589 |
| 82 | PAK4 | 0.69298003 |
| 83 | GRK5 | 0.68639862 |
| 84 | RPS6KA1 | 0.66506787 |
| 85 | BCR | 0.65696546 |
| 86 | PINK1 | 0.65205333 |
| 87 | ERBB3 | 0.64980281 |
| 88 | RET | 0.64759399 |
| 89 | MAP3K6 | 0.64513224 |
| 90 | DAPK3 | 0.64400990 |
| 91 | PKN1 | 0.63005026 |
| 92 | CAMK2G | 0.61830621 |
| 93 | PAK3 | 0.61424222 |
| 94 | NEK1 | 0.60574020 |
| 95 | EEF2K | 0.58798856 |
| 96 | PRKD1 | 0.58525999 |
| 97 | MET | 0.58122459 |
| 98 | ROCK2 | 0.57593673 |
| 99 | KDR | 0.57593163 |
| 100 | FGFR4 | 0.56294599 |
| 101 | PRKG2 | 0.55578688 |
| 102 | NUAK1 | 0.55453722 |
| 103 | MOS | 0.54969389 |
| 104 | MAP3K1 | 0.54763430 |
| 105 | GSK3A | 0.54168386 |
| 106 | MAPK4 | 0.54010230 |
| 107 | PRKAA1 | 0.51212027 |
| 108 | MAP2K1 | 0.50309853 |
| 109 | MAPK7 | 0.49243397 |
| 110 | STK10 | 0.48637384 |
| 111 | PBK | 0.48167789 |
| 112 | WNK4 | 0.47189544 |
| 113 | EPHB1 | 0.46087186 |
| 114 | SMG1 | 0.45977768 |
| 115 | ERN1 | 0.44699025 |
| 116 | PAK1 | 0.44585695 |
| 117 | PDK1 | 0.44350488 |
| 118 | RPS6KB2 | 0.43919723 |
| 119 | MAP3K7 | 0.43233254 |
| 120 | MAPKAPK5 | 0.43084394 |
| 121 | ZAP70 | 0.42007447 |
| 122 | IRAK3 | 0.41629060 |
| 123 | DYRK1B | 0.41169515 |
| 124 | PIK3CG | 0.39625995 |
| 125 | TGFBR2 | 0.38815164 |
| 126 | EIF2AK1 | 0.38356806 |
| 127 | PRKG1 | 0.38208550 |
| 128 | CDK4 | 0.37272672 |
| 129 | SCYL2 | 0.37217697 |
| 130 | PLK4 | 0.36719273 |
| 131 | DAPK2 | 0.36701490 |
| 132 | PIM1 | 0.36164435 |
| 133 | AKT1 | 0.35654499 |
| 134 | SRC | 0.34454900 |
| 135 | EGFR | 0.34395077 |
| 136 | TIE1 | 0.33427633 |
| 137 | MTOR | 0.32582002 |
| 138 | PRKACG | 0.32336707 |
| 139 | PRPF4B | 0.31464108 |
| 140 | CAMK4 | 0.31269702 |
| 141 | CSF1R | 0.30499978 |
| 142 | CSK | 0.29343494 |
| 143 | RIPK4 | 0.29168143 |
| 144 | NEK2 | 0.27299979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.04778143 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.66366646 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.85716175 |
| 4 | Focal adhesion_Homo sapiens_hsa04510 | 2.84344397 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.80511292 |
| 6 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.69273069 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.65520177 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.29886956 |
| 9 | Amoebiasis_Homo sapiens_hsa05146 | 2.20849475 |
| 10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.19672520 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 2.17050346 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.16773099 |
| 13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.13760466 |
| 14 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 2.11319780 |
| 15 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.10736706 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.09894465 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.04508354 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92861858 |
| 19 | * Basal cell carcinoma_Homo sapiens_hsa05217 | 1.84945003 |
| 20 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.84890432 |
| 21 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.80118359 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.78838502 |
| 23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.73652654 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.72765679 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71175781 |
| 26 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.71118450 |
| 27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.63845892 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.52149743 |
| 29 | Tight junction_Homo sapiens_hsa04530 | 1.49434995 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.43008543 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.42620706 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.41797804 |
| 33 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.37764360 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37561597 |
| 35 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.34252637 |
| 36 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.30802798 |
| 37 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.27714759 |
| 38 | * Pathways in cancer_Homo sapiens_hsa05200 | 1.24726900 |
| 39 | * Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.23383635 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22682239 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21061476 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 1.20884930 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20881234 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17898556 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15405313 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13533775 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.13305877 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.12357847 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11842708 |
| 50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.11615796 |
| 51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.11376561 |
| 52 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10387660 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07431457 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07042886 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 1.03633919 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03270130 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00512342 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00272973 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99156082 |
| 60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94683014 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.93862853 |
| 62 | * Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.93024516 |
| 63 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.92692003 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92571511 |
| 65 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90417490 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88069997 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87805568 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.87756501 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87698051 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86943060 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85983056 |
| 72 | * Melanogenesis_Homo sapiens_hsa04916 | 0.85849632 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85547805 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85184656 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.85137738 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84509110 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84070336 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83250981 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82112677 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81453144 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.81258624 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80192711 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80152236 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79487287 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79157474 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78895641 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.78441914 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77382733 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76381824 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75841521 |
| 91 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75221471 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72821480 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72637654 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72002250 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71928557 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71187218 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70183868 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70102605 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69903467 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66940173 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65841978 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65557270 |
| 103 | * Wnt signaling pathway_Homo sapiens_hsa04310 | 0.65488497 |
| 104 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64893177 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.64418489 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64090760 |
| 107 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63727188 |
| 108 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63255296 |
| 109 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62868325 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.61790760 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61501779 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61460092 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60956242 |
| 114 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60730808 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60699357 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60531044 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58118488 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.58025040 |
| 119 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57739581 |
| 120 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57421678 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57172921 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.56851989 |
| 123 | Melanoma_Homo sapiens_hsa05218 | 0.56259574 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54744180 |
| 125 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53264223 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53058819 |
| 127 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50924094 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50390586 |
| 129 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50154551 |
| 130 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50138217 |
| 131 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49983240 |
| 132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49310131 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48031188 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47345855 |
| 135 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47314145 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46981224 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46881332 |
| 138 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46648971 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46628749 |
| 140 | Legionellosis_Homo sapiens_hsa05134 | 0.45410356 |
| 141 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45140043 |
| 142 | Salmonella infection_Homo sapiens_hsa05132 | 0.44836010 |
| 143 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44039532 |
| 144 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43815552 |
| 145 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43729000 |
| 146 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41818985 |
| 147 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41733000 |
| 148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41541623 |
| 149 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40520899 |
| 150 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40284106 |
| 151 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38042002 |
| 152 | Renin secretion_Homo sapiens_hsa04924 | 0.37928626 |
| 153 | ABC transporters_Homo sapiens_hsa02010 | 0.37707400 |
| 154 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37469726 |
| 155 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37439425 |
| 156 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35696829 |
| 157 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34734497 |
| 158 | Peroxisome_Homo sapiens_hsa04146 | 0.33880710 |

